What is Scriptura Health?

Scriptura Health is clinical decision support and clinical intelligence infrastructure for cash-pay longevity practices. It is not an EHR, not telemedicine, and not a pharmacy. The clinician always diagnoses, prescribes, and signs.

Who founded Scriptura Health?

Scriptura Health was founded by John Murray and Sabrina Runbeck, MPH, MHS, PA-C. John is a healthcare entrepreneur and patient advocate whose personal journey through recovery, chronic pain, sleep health, and longevity optimization inspired a mission to help clinicians and patients navigate increasingly complex healthcare decisions. Sabrina is a Physician Associate with more than 16 years of experience across cardiothoracic surgery, hospital medicine, emergency medicine, and public health. Licensed in eight states, she has supported more than 14 hospital systems throughout her career and advised healthcare organizations, founders, and investors on clinical strategy and healthcare delivery. Together, they built Scriptura to help clinicians deliver safer, more informed, and more efficient longevity care.

What is The Sequence Method?

The Sequence Method is an eight-stage clinical workflow: Intake, Lab Read, Risk Band, Priority Stack, Intervention, Sequence, Clinical Follow-up, and Re-entry. Every recommendation carries a defensible rationale.

Is Scriptura Health HIPAA compliant?

Scriptura operates as a HIPAA Business Associate under 45 CFR Part 164 Subpart C. Infrastructure is AWS-native, with BAA available on request. The company is pre-production and has not yet processed live patient data. Scriptura makes no third-party certification claims.

Which EHR systems does Scriptura integrate with?

Scriptura embeds through EMRAY, which carries signed integrations with Epic, Oracle Health, AdvancedMD, CharmHealth, NextGen Healthcare, and eClinicalWorks. Additional EHR support is added upon request.

How is Scriptura different from MyDose?

Scriptura and MyDose serve overlapping practices but do different jobs. MyDose is clinic management software that replaces the operational system. Scriptura is clinical decision support that makes prescribing decisions defensible inside the EHR the practice already uses. Scriptura embeds through EMRAY, which carries signed integrations with Epic, Oracle Health, AdvancedMD, CharmHealth, NextGen Healthcare, and eClinicalWorks. MyDose asks the practice to switch platforms.

Is Scriptura the same as consumer peptide tracking apps like PeptIQ or PeptideAI?

No. Consumer peptide apps and direct-to-consumer telehealth serve patients directly. Scriptura is decision support for the prescriber. Scriptura sometimes appears alongside those tools in search results, but it is not the same product or the same buyer.

What does Scriptura monitor for regulatory changes?

Scriptura monitors four federal regulators (FDA, DEA, FTC, USP) and all fifty state medical and pharmacy boards. The federal scan runs daily at 7am ET. State board scans roll out weekly. Details are on the Regulatory page.

Scriptura blog

Read the evidence before the decision.

We write for licensed clinicians who want the research, the safety checks and the regulations in one place before a treatment decision. Each article answers one clinical question, sourced to the primary document and dated.

Latest articles

15 articles

Safety & Regulatory Alerts
Can Clinics Prescribe Compounded BPC-157 and TB-500 Now? What the HHS 503A Peptide Policy Allows

Yes, under conditions. HHS's Oct 2026 policy allows 503A compounding of BPC-157, TB-500 and 4 other peptides. The 10 pharmacy conditions and prescriber checklist.

Oct 29, 202613 min read
Safety & Regulatory Alerts
HHS peptide enforcement discretion policy, October 2026: what it allows and what it does not

On October 28, 2026, HHS filed an interim policy saying it does not intend to act against 503A compounding of BPC-157, Epitalon, KPV, MOTS-c, Semax or TB-500 under ten conditions. Nothing was approved and no list changed.

Oct 29, 202610 min read
Before You Prescribe
Clinical Decision Intelligence: Which labs to order before and during peptide therapy, and how to document each decision

For peptide therapy, a defensible clinical decision has three parts: a baseline lab panel taken before the first dose, monitoring matched to the specific…

Oct 22, 202614 min read
Safety & Regulatory Alerts
Can I legally prescribe peptides in 2026? What the FDA, your state board and USP each require

No peptide removed from the FDA's Category 2 list has been added to the 503A bulk list, so compounding the six peptides backed by the July PCAC votes still has no federal basis.

Oct 22, 202621 min read
Safety & Regulatory Alerts
FDA PCAC July 2026: What The Peptide Committee Decided

On July 23 and 24, 2026, the FDA's Pharmacy Compounding Advisory Committee recommended six of seven peptides for the 503A bulks list: BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon.

Oct 22, 202614 min read
Safety & Regulatory Alerts
Is injectable glutathione safe after the 2026 recalls? Only if your pharmacy can prove the ingredient was made for injection

This is for MDs, DOs, NPs, PAs, and the nurses who run injection and IV services in longevity, functional, aesthetic, and cash-pay clinics that stock glutathione.

Oct 22, 202613 min read
Safety & Regulatory Alerts
The 12 peptides removed from Category 2 in April 2026

None of the 12 peptides the FDA removed from Category 2 on April 15, 2026 has been placed in Category 1 or on the 503A bulks list.

Oct 22, 202615 min read
New Research, New Evidence
Are there BPC-157 human trials? Almost none controlled: here is the human evidence for BPC-157 and the other five PCAC peptides

As of October 19, 2026, none of the six peptides FDA's advisers recommended in July (BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon) has a completed…

Oct 22, 202613 min read
Safety & Regulatory Alerts
Alabama Peptide Enforcement Action 2026: What Every NP, PA, MD, and DO Needs to Know

In a notice published in May 2026 and reported by WSFA on May 26, the Alabama Board of Medical Examiners barred physicians from compounding, administering…

Oct 22, 202618 min read
Grow Your Practice
Clinical decision support systems vs AI chatbots

Clinical decision support systems and AI chatbots can both inform care, but neither label proves a tool is clinically validated or keeps an adequate audit trail.

Oct 22, 202617 min read
New Research, New Evidence
Is testosterone for menopausal women evidence-based?

What evidence supports testosterone for menopausal women? HSDD guidance, safety limits, and the FDA comment window.

Oct 19, 202613 min read
Find the Root Cause
The visit should start before the patient walks in

Scriptura’s product direction starts with prepared patients, timely context, and clinical intelligence that strengthens the clinician’s judgment.

Sep 20, 20262 min read
Safety & Regulatory Alerts
Why regulations are changing faster than clinics realize

FDA compounding rules, DEA scheduling, PCAC meetings, and state pharmacy actions are moving fast. Here is how longevity clinics stay ahead.

Jul 8, 20261 min read
New Research, New Evidence
How to stay current without reading hundreds of PubMed papers

New peptide and biomarker research every day. Almost none of it changes Monday. Here is how to find the studies that actually matter.

Jul 8, 20261 min read
Grow Your Practice
Most practices do not need another staff member. They need better systems.

Documentation, retention, capacity, and growth all break when workflows are improvised. Here is how longevity clinics fix the operational layer.

Jul 8, 20261 min read

For clinics

See how Scriptura fits your clinic

Clinical decision-support software for licensed practitioners. You review, edit and sign every plan.

Book a demo

Talk with the Scriptura team.

Read the evidence before the decision.

Latest articles

Can Clinics Prescribe Compounded BPC-157 and TB-500 Now? What the HHS 503A Peptide Policy Allows

HHS peptide enforcement discretion policy, October 2026: what it allows and what it does not

Clinical Decision Intelligence: Which labs to order before and during peptide therapy, and how to document each decision

Can I legally prescribe peptides in 2026? What the FDA, your state board and USP each require

FDA PCAC July 2026: What The Peptide Committee Decided

Is injectable glutathione safe after the 2026 recalls? Only if your pharmacy can prove the ingredient was made for injection

The 12 peptides removed from Category 2 in April 2026

Are there BPC-157 human trials? Almost none controlled: here is the human evidence for BPC-157 and the other five PCAC peptides

Alabama Peptide Enforcement Action 2026: What Every NP, PA, MD, and DO Needs to Know

Clinical decision support systems vs AI chatbots

Is testosterone for menopausal women evidence-based?

The visit should start before the patient walks in

Why regulations are changing faster than clinics realize

How to stay current without reading hundreds of PubMed papers

Most practices do not need another staff member. They need better systems.

Published articles will appear here

Looking for something specific?

See how Scriptura fits your clinic

Read the evidence before the decision.

Published articles will appear here

Looking for something specific?

See how Scriptura fits your clinic

New rules and new evidence, the week they land.